Induced Pluripotent Stem Cells (iPSC) are generated from skin or blood cells that have been reprogrammed into an embryonic-like pluripotent state, allowing to produce an infinite source of any kind of human cell required for therapeutic reasons.
This report aims to provide a comprehensive presentation of the global market for Induced Pluripotent Stem Cells Production, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Induced Pluripotent Stem Cells Production. This report contains market size and forecasts of Induced Pluripotent Stem Cells Production in global, including the following market information:
Global Induced Pluripotent Stem Cells Production Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Induced Pluripotent Stem Cells Production Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Induced Pluripotent Stem Cells Production companies in 2022 (%)
The global Induced Pluripotent Stem Cells Production market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Hepatocytes Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Induced Pluripotent Stem Cells Production include Lonza, Axol Bioscience Ltd., Evotec, Hitachi Ltd., Merck KGaA, REPROCELL Inc., Fate Therapeutics, Thermo Fisher Scientific, Inc. and StemCellFactory III, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Induced Pluripotent Stem Cells Production manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Induced Pluripotent Stem Cells Production Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Induced Pluripotent Stem Cells Production Market Segment Percentages, by Type, 2022 (%)
Hepatocytes
Fibroblasts
Keratinocytes
Amniotic Cells
Others
Global Induced Pluripotent Stem Cells Production Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Induced Pluripotent Stem Cells Production Market Segment Percentages, by Application, 2022 (%)
Academic Research
Drug Development
Toxicity Screening
Regenerative Medicine
Global Induced Pluripotent Stem Cells Production Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Induced Pluripotent Stem Cells Production Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Induced Pluripotent Stem Cells Production revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Induced Pluripotent Stem Cells Production revenues share in global market, 2022 (%)
Key companies Induced Pluripotent Stem Cells Production sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Induced Pluripotent Stem Cells Production sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Lonza
Axol Bioscience Ltd.
Evotec
Hitachi Ltd.
Merck KGaA
REPROCELL Inc.
Fate Therapeutics
Thermo Fisher Scientific, Inc.
StemCellFactory III
Applied StemCell Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Induced Pluripotent Stem Cells Production, market overview.
Chapter 2: Global Induced Pluripotent Stem Cells Production market size in revenue and volume.
Chapter 3: Detailed analysis of Induced Pluripotent Stem Cells Production manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Induced Pluripotent Stem Cells Production in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Induced Pluripotent Stem Cells Production capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Induced Pluripotent Stem Cells Production Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Induced Pluripotent Stem Cells Production Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Induced Pluripotent Stem Cells Production Overall Market Size
2.1 Global Induced Pluripotent Stem Cells Production Market Size: 2022 VS 2029
2.2 Global Induced Pluripotent Stem Cells Production Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Induced Pluripotent Stem Cells Production Sales: 2018-2029
3 Company Landscape
3.1 Top Induced Pluripotent Stem Cells Production Players in Global Market
3.2 Top Global Induced Pluripotent Stem Cells Production Companies Ranked by Revenue
3.3 Global Induced Pluripotent Stem Cells Production Revenue by Companies
3.4 Global Induced Pluripotent Stem Cells Production Sales by Companies
3.5 Global Induced Pluripotent Stem Cells Production Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Induced Pluripotent Stem Cells Production Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Induced Pluripotent Stem Cells Production Product Type
3.8 Tier 1, Tier 2 and Tier 3 Induced Pluripotent Stem Cells Production Players in Global Market
3.8.1 List of Global Tier 1 Induced Pluripotent Stem Cells Production Companies
3.8.2 List of Global Tier 2 and Tier 3 Induced Pluripotent Stem Cells Production Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Induced Pluripotent Stem Cells Production Market Size Markets, 2022 & 2029
4.1.2 Hepatocytes
4.1.3 Fibroblasts
4.1.4 Keratinocytes
4.1.5 Amniotic Cells
4.1.6 Others
4.2 By Type - Global Induced Pluripotent Stem Cells Production Revenue & Forecasts
4.2.1 By Type - Global Induced Pluripotent Stem Cells Production Revenue, 2018-2023
4.2.2 By Type - Global Induced Pluripotent Stem Cells Production Revenue, 2024-2029
4.2.3 By Type - Global Induced Pluripotent Stem Cells Production Revenue Market Share, 2018-2029
4.3 By Type - Global Induced Pluripotent Stem Cells Production Sales & Forecasts
4.3.1 By Type - Global Induced Pluripotent Stem Cells Production Sales, 2018-2023
4.3.2 By Type - Global Induced Pluripotent Stem Cells Production Sales, 2024-2029
4.3.3 By Type - Global Induced Pluripotent Stem Cells Production Sales Market Share, 2018-2029
4.4 By Type - Global Induced Pluripotent Stem Cells Production Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Induced Pluripotent Stem Cells Production Market Size, 2022 & 2029
5.1.2 Academic Research
5.1.3 Drug Development
5.1.4 Toxicity Screening
5.1.5 Regenerative Medicine
5.2 By Application - Global Induced Pluripotent Stem Cells Production Revenue & Forecasts
5.2.1 By Application - Global Induced Pluripotent Stem Cells Production Revenue, 2018-2023
5.2.2 By Application - Global Induced Pluripotent Stem Cells Production Revenue, 2024-2029
5.2.3 By Application - Global Induced Pluripotent Stem Cells Production Revenue Market Share, 2018-2029
5.3 By Application - Global Induced Pluripotent Stem Cells Production Sales & Forecasts
5.3.1 By Application - Global Induced Pluripotent Stem Cells Production Sales, 2018-2023
5.3.2 By Application - Global Induced Pluripotent Stem Cells Production Sales, 2024-2029
5.3.3 By Application - Global Induced Pluripotent Stem Cells Production Sales Market Share, 2018-2029
5.4 By Application - Global Induced Pluripotent Stem Cells Production Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Induced Pluripotent Stem Cells Production Market Size, 2022 & 2029
6.2 By Region - Global Induced Pluripotent Stem Cells Production Revenue & Forecasts
6.2.1 By Region - Global Induced Pluripotent Stem Cells Production Revenue, 2018-2023
6.2.2 By Region - Global Induced Pluripotent Stem Cells Production Revenue, 2024-2029
6.2.3 By Region - Global Induced Pluripotent Stem Cells Production Revenue Market Share, 2018-2029
6.3 By Region - Global Induced Pluripotent Stem Cells Production Sales & Forecasts
6.3.1 By Region - Global Induced Pluripotent Stem Cells Production Sales, 2018-2023
6.3.2 By Region - Global Induced Pluripotent Stem Cells Production Sales, 2024-2029
6.3.3 By Region - Global Induced Pluripotent Stem Cells Production Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Induced Pluripotent Stem Cells Production Revenue, 2018-2029
6.4.2 By Country - North America Induced Pluripotent Stem Cells Production Sales, 2018-2029
6.4.3 US Induced Pluripotent Stem Cells Production Market Size, 2018-2029
6.4.4 Canada Induced Pluripotent Stem Cells Production Market Size, 2018-2029
6.4.5 Mexico Induced Pluripotent Stem Cells Production Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Induced Pluripotent Stem Cells Production Revenue, 2018-2029
6.5.2 By Country - Europe Induced Pluripotent Stem Cells Production Sales, 2018-2029
6.5.3 Germany Induced Pluripotent Stem Cells Production Market Size, 2018-2029
6.5.4 France Induced Pluripotent Stem Cells Production Market Size, 2018-2029
6.5.5 U.K. Induced Pluripotent Stem Cells Production Market Size, 2018-2029
6.5.6 Italy Induced Pluripotent Stem Cells Production Market Size, 2018-2029
6.5.7 Russia Induced Pluripotent Stem Cells Production Market Size, 2018-2029
6.5.8 Nordic Countries Induced Pluripotent Stem Cells Production Market Size, 2018-2029
6.5.9 Benelux Induced Pluripotent Stem Cells Production Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Induced Pluripotent Stem Cells Production Revenue, 2018-2029
6.6.2 By Region - Asia Induced Pluripotent Stem Cells Production Sales, 2018-2029
6.6.3 China Induced Pluripotent Stem Cells Production Market Size, 2018-2029
6.6.4 Japan Induced Pluripotent Stem Cells Production Market Size, 2018-2029
6.6.5 South Korea Induced Pluripotent Stem Cells Production Market Size, 2018-2029
6.6.6 Southeast Asia Induced Pluripotent Stem Cells Production Market Size, 2018-2029
6.6.7 India Induced Pluripotent Stem Cells Production Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Induced Pluripotent Stem Cells Production Revenue, 2018-2029
6.7.2 By Country - South America Induced Pluripotent Stem Cells Production Sales, 2018-2029
6.7.3 Brazil Induced Pluripotent Stem Cells Production Market Size, 2018-2029
6.7.4 Argentina Induced Pluripotent Stem Cells Production Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Induced Pluripotent Stem Cells Production Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Induced Pluripotent Stem Cells Production Sales, 2018-2029
6.8.3 Turkey Induced Pluripotent Stem Cells Production Market Size, 2018-2029
6.8.4 Israel Induced Pluripotent Stem Cells Production Market Size, 2018-2029
6.8.5 Saudi Arabia Induced Pluripotent Stem Cells Production Market Size, 2018-2029
6.8.6 UAE Induced Pluripotent Stem Cells Production Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Lonza
7.1.1 Lonza Company Summary
7.1.2 Lonza Business Overview
7.1.3 Lonza Induced Pluripotent Stem Cells Production Major Product Offerings
7.1.4 Lonza Induced Pluripotent Stem Cells Production Sales and Revenue in Global (2018-2023)
7.1.5 Lonza Key News & Latest Developments
7.2 Axol Bioscience Ltd.
7.2.1 Axol Bioscience Ltd. Company Summary
7.2.2 Axol Bioscience Ltd. Business Overview
7.2.3 Axol Bioscience Ltd. Induced Pluripotent Stem Cells Production Major Product Offerings
7.2.4 Axol Bioscience Ltd. Induced Pluripotent Stem Cells Production Sales and Revenue in Global (2018-2023)
7.2.5 Axol Bioscience Ltd. Key News & Latest Developments
7.3 Evotec
7.3.1 Evotec Company Summary
7.3.2 Evotec Business Overview
7.3.3 Evotec Induced Pluripotent Stem Cells Production Major Product Offerings
7.3.4 Evotec Induced Pluripotent Stem Cells Production Sales and Revenue in Global (2018-2023)
7.3.5 Evotec Key News & Latest Developments
7.4 Hitachi Ltd.
7.4.1 Hitachi Ltd. Company Summary
7.4.2 Hitachi Ltd. Business Overview
7.4.3 Hitachi Ltd. Induced Pluripotent Stem Cells Production Major Product Offerings
7.4.4 Hitachi Ltd. Induced Pluripotent Stem Cells Production Sales and Revenue in Global (2018-2023)
7.4.5 Hitachi Ltd. Key News & Latest Developments
7.5 Merck KGaA
7.5.1 Merck KGaA Company Summary
7.5.2 Merck KGaA Business Overview
7.5.3 Merck KGaA Induced Pluripotent Stem Cells Production Major Product Offerings
7.5.4 Merck KGaA Induced Pluripotent Stem Cells Production Sales and Revenue in Global (2018-2023)
7.5.5 Merck KGaA Key News & Latest Developments
7.6 REPROCELL Inc.
7.6.1 REPROCELL Inc. Company Summary
7.6.2 REPROCELL Inc. Business Overview
7.6.3 REPROCELL Inc. Induced Pluripotent Stem Cells Production Major Product Offerings
7.6.4 REPROCELL Inc. Induced Pluripotent Stem Cells Production Sales and Revenue in Global (2018-2023)
7.6.5 REPROCELL Inc. Key News & Latest Developments
7.7 Fate Therapeutics
7.7.1 Fate Therapeutics Company Summary
7.7.2 Fate Therapeutics Business Overview
7.7.3 Fate Therapeutics Induced Pluripotent Stem Cells Production Major Product Offerings
7.7.4 Fate Therapeutics Induced Pluripotent Stem Cells Production Sales and Revenue in Global (2018-2023)
7.7.5 Fate Therapeutics Key News & Latest Developments
7.8 Thermo Fisher Scientific, Inc.
7.8.1 Thermo Fisher Scientific, Inc. Company Summary
7.8.2 Thermo Fisher Scientific, Inc. Business Overview
7.8.3 Thermo Fisher Scientific, Inc. Induced Pluripotent Stem Cells Production Major Product Offerings
7.8.4 Thermo Fisher Scientific, Inc. Induced Pluripotent Stem Cells Production Sales and Revenue in Global (2018-2023)
7.8.5 Thermo Fisher Scientific, Inc. Key News & Latest Developments
7.9 StemCellFactory III
7.9.1 StemCellFactory III Company Summary
7.9.2 StemCellFactory III Business Overview
7.9.3 StemCellFactory III Induced Pluripotent Stem Cells Production Major Product Offerings
7.9.4 StemCellFactory III Induced Pluripotent Stem Cells Production Sales and Revenue in Global (2018-2023)
7.9.5 StemCellFactory III Key News & Latest Developments
7.10 Applied StemCell Inc.
7.10.1 Applied StemCell Inc. Company Summary
7.10.2 Applied StemCell Inc. Business Overview
7.10.3 Applied StemCell Inc. Induced Pluripotent Stem Cells Production Major Product Offerings
7.10.4 Applied StemCell Inc. Induced Pluripotent Stem Cells Production Sales and Revenue in Global (2018-2023)
7.10.5 Applied StemCell Inc. Key News & Latest Developments
8 Global Induced Pluripotent Stem Cells Production Production Capacity, Analysis
8.1 Global Induced Pluripotent Stem Cells Production Production Capacity, 2018-2029
8.2 Induced Pluripotent Stem Cells Production Production Capacity of Key Manufacturers in Global Market
8.3 Global Induced Pluripotent Stem Cells Production Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Induced Pluripotent Stem Cells Production Supply Chain Analysis
10.1 Induced Pluripotent Stem Cells Production Industry Value Chain
10.2 Induced Pluripotent Stem Cells Production Upstream Market
10.3 Induced Pluripotent Stem Cells Production Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Induced Pluripotent Stem Cells Production Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Induced Pluripotent Stem Cells Production in Global Market
Table 2. Top Induced Pluripotent Stem Cells Production Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Induced Pluripotent Stem Cells Production Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Induced Pluripotent Stem Cells Production Revenue Share by Companies, 2018-2023
Table 5. Global Induced Pluripotent Stem Cells Production Sales by Companies, (K Units), 2018-2023
Table 6. Global Induced Pluripotent Stem Cells Production Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Induced Pluripotent Stem Cells Production Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Induced Pluripotent Stem Cells Production Product Type
Table 9. List of Global Tier 1 Induced Pluripotent Stem Cells Production Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Induced Pluripotent Stem Cells Production Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Induced Pluripotent Stem Cells Production Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Induced Pluripotent Stem Cells Production Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Induced Pluripotent Stem Cells Production Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Induced Pluripotent Stem Cells Production Sales (K Units), 2018-2023
Table 15. By Type - Global Induced Pluripotent Stem Cells Production Sales (K Units), 2024-2029
Table 16. By Application ? Global Induced Pluripotent Stem Cells Production Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Induced Pluripotent Stem Cells Production Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Induced Pluripotent Stem Cells Production Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Induced Pluripotent Stem Cells Production Sales (K Units), 2018-2023
Table 20. By Application - Global Induced Pluripotent Stem Cells Production Sales (K Units), 2024-2029
Table 21. By Region ? Global Induced Pluripotent Stem Cells Production Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Induced Pluripotent Stem Cells Production Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Induced Pluripotent Stem Cells Production Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Induced Pluripotent Stem Cells Production Sales (K Units), 2018-2023
Table 25. By Region - Global Induced Pluripotent Stem Cells Production Sales (K Units), 2024-2029
Table 26. By Country - North America Induced Pluripotent Stem Cells Production Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Induced Pluripotent Stem Cells Production Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Induced Pluripotent Stem Cells Production Sales, (K Units), 2018-2023
Table 29. By Country - North America Induced Pluripotent Stem Cells Production Sales, (K Units), 2024-2029
Table 30. By Country - Europe Induced Pluripotent Stem Cells Production Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Induced Pluripotent Stem Cells Production Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Induced Pluripotent Stem Cells Production Sales, (K Units), 2018-2023
Table 33. By Country - Europe Induced Pluripotent Stem Cells Production Sales, (K Units), 2024-2029
Table 34. By Region - Asia Induced Pluripotent Stem Cells Production Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Induced Pluripotent Stem Cells Production Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Induced Pluripotent Stem Cells Production Sales, (K Units), 2018-2023
Table 37. By Region - Asia Induced Pluripotent Stem Cells Production Sales, (K Units), 2024-2029
Table 38. By Country - South America Induced Pluripotent Stem Cells Production Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Induced Pluripotent Stem Cells Production Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Induced Pluripotent Stem Cells Production Sales, (K Units), 2018-2023
Table 41. By Country - South America Induced Pluripotent Stem Cells Production Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Induced Pluripotent Stem Cells Production Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Induced Pluripotent Stem Cells Production Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Induced Pluripotent Stem Cells Production Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Induced Pluripotent Stem Cells Production Sales, (K Units), 2024-2029
Table 46. Lonza Company Summary
Table 47. Lonza Induced Pluripotent Stem Cells Production Product Offerings
Table 48. Lonza Induced Pluripotent Stem Cells Production Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Lonza Key News & Latest Developments
Table 50. Axol Bioscience Ltd. Company Summary
Table 51. Axol Bioscience Ltd. Induced Pluripotent Stem Cells Production Product Offerings
Table 52. Axol Bioscience Ltd. Induced Pluripotent Stem Cells Production Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Axol Bioscience Ltd. Key News & Latest Developments
Table 54. Evotec Company Summary
Table 55. Evotec Induced Pluripotent Stem Cells Production Product Offerings
Table 56. Evotec Induced Pluripotent Stem Cells Production Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Evotec Key News & Latest Developments
Table 58. Hitachi Ltd. Company Summary
Table 59. Hitachi Ltd. Induced Pluripotent Stem Cells Production Product Offerings
Table 60. Hitachi Ltd. Induced Pluripotent Stem Cells Production Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Hitachi Ltd. Key News & Latest Developments
Table 62. Merck KGaA Company Summary
Table 63. Merck KGaA Induced Pluripotent Stem Cells Production Product Offerings
Table 64. Merck KGaA Induced Pluripotent Stem Cells Production Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Merck KGaA Key News & Latest Developments
Table 66. REPROCELL Inc. Company Summary
Table 67. REPROCELL Inc. Induced Pluripotent Stem Cells Production Product Offerings
Table 68. REPROCELL Inc. Induced Pluripotent Stem Cells Production Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. REPROCELL Inc. Key News & Latest Developments
Table 70. Fate Therapeutics Company Summary
Table 71. Fate Therapeutics Induced Pluripotent Stem Cells Production Product Offerings
Table 72. Fate Therapeutics Induced Pluripotent Stem Cells Production Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Fate Therapeutics Key News & Latest Developments
Table 74. Thermo Fisher Scientific, Inc. Company Summary
Table 75. Thermo Fisher Scientific, Inc. Induced Pluripotent Stem Cells Production Product Offerings
Table 76. Thermo Fisher Scientific, Inc. Induced Pluripotent Stem Cells Production Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Thermo Fisher Scientific, Inc. Key News & Latest Developments
Table 78. StemCellFactory III Company Summary
Table 79. StemCellFactory III Induced Pluripotent Stem Cells Production Product Offerings
Table 80. StemCellFactory III Induced Pluripotent Stem Cells Production Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. StemCellFactory III Key News & Latest Developments
Table 82. Applied StemCell Inc. Company Summary
Table 83. Applied StemCell Inc. Induced Pluripotent Stem Cells Production Product Offerings
Table 84. Applied StemCell Inc. Induced Pluripotent Stem Cells Production Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 85. Applied StemCell Inc. Key News & Latest Developments
Table 86. Induced Pluripotent Stem Cells Production Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 87. Global Induced Pluripotent Stem Cells Production Capacity Market Share of Key Manufacturers, 2021-2023
Table 88. Global Induced Pluripotent Stem Cells Production Production by Region, 2018-2023 (K Units)
Table 89. Global Induced Pluripotent Stem Cells Production Production by Region, 2024-2029 (K Units)
Table 90. Induced Pluripotent Stem Cells Production Market Opportunities & Trends in Global Market
Table 91. Induced Pluripotent Stem Cells Production Market Drivers in Global Market
Table 92. Induced Pluripotent Stem Cells Production Market Restraints in Global Market
Table 93. Induced Pluripotent Stem Cells Production Raw Materials
Table 94. Induced Pluripotent Stem Cells Production Raw Materials Suppliers in Global Market
Table 95. Typical Induced Pluripotent Stem Cells Production Downstream
Table 96. Induced Pluripotent Stem Cells Production Downstream Clients in Global Market
Table 97. Induced Pluripotent Stem Cells Production Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Induced Pluripotent Stem Cells Production Segment by Type in 2022
Figure 2. Induced Pluripotent Stem Cells Production Segment by Application in 2022
Figure 3. Global Induced Pluripotent Stem Cells Production Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Induced Pluripotent Stem Cells Production Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Induced Pluripotent Stem Cells Production Revenue, 2018-2029 (US$, Mn)
Figure 7. Induced Pluripotent Stem Cells Production Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Induced Pluripotent Stem Cells Production Revenue in 2022
Figure 9. By Type - Global Induced Pluripotent Stem Cells Production Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Induced Pluripotent Stem Cells Production Revenue Market Share, 2018-2029
Figure 11. By Type - Global Induced Pluripotent Stem Cells Production Sales Market Share, 2018-2029
Figure 12. By Type - Global Induced Pluripotent Stem Cells Production Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Induced Pluripotent Stem Cells Production Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Induced Pluripotent Stem Cells Production Revenue Market Share, 2018-2029
Figure 15. By Application - Global Induced Pluripotent Stem Cells Production Sales Market Share, 2018-2029
Figure 16. By Application - Global Induced Pluripotent Stem Cells Production Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Induced Pluripotent Stem Cells Production Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Induced Pluripotent Stem Cells Production Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Induced Pluripotent Stem Cells Production Revenue Market Share, 2018-2029
Figure 20. By Region - Global Induced Pluripotent Stem Cells Production Sales Market Share, 2018-2029
Figure 21. By Country - North America Induced Pluripotent Stem Cells Production Revenue Market Share, 2018-2029
Figure 22. By Country - North America Induced Pluripotent Stem Cells Production Sales Market Share, 2018-2029
Figure 23. US Induced Pluripotent Stem Cells Production Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Induced Pluripotent Stem Cells Production Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Induced Pluripotent Stem Cells Production Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Induced Pluripotent Stem Cells Production Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Induced Pluripotent Stem Cells Production Sales Market Share, 2018-2029
Figure 28. Germany Induced Pluripotent Stem Cells Production Revenue, (US$, Mn), 2018-2029
Figure 29. France Induced Pluripotent Stem Cells Production Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Induced Pluripotent Stem Cells Production Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Induced Pluripotent Stem Cells Production Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Induced Pluripotent Stem Cells Production Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Induced Pluripotent Stem Cells Production Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Induced Pluripotent Stem Cells Production Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Induced Pluripotent Stem Cells Production Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Induced Pluripotent Stem Cells Production Sales Market Share, 2018-2029
Figure 37. China Induced Pluripotent Stem Cells Production Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Induced Pluripotent Stem Cells Production Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Induced Pluripotent Stem Cells Production Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Induced Pluripotent Stem Cells Production Revenue, (US$, Mn), 2018-2029
Figure 41. India Induced Pluripotent Stem Cells Production Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Induced Pluripotent Stem Cells Production Revenue Market Share, 2018-2029
Figure 43. By Country - South America Induced Pluripotent Stem Cells Production Sales Market Share, 2018-2029
Figure 44. Brazil Induced Pluripotent Stem Cells Production Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Induced Pluripotent Stem Cells Production Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Induced Pluripotent Stem Cells Production Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Induced Pluripotent Stem Cells Production Sales Market Share, 2018-2029
Figure 48. Turkey Induced Pluripotent Stem Cells Production Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Induced Pluripotent Stem Cells Production Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Induced Pluripotent Stem Cells Production Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Induced Pluripotent Stem Cells Production Revenue, (US$, Mn), 2018-2029
Figure 52. Global Induced Pluripotent Stem Cells Production Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Induced Pluripotent Stem Cells Production by Region, 2022 VS 2029
Figure 54. Induced Pluripotent Stem Cells Production Industry Value Chain
Figure 55. Marketing Channels
